Hans Heugh Wandall

PersonUnit number: 4000456347
Esperance Alle 18, 2920 Charlottenlund
1
Ownership
5
Board positions
6
Director positions
2
Other roles
20
People in network

People in network(20)

People who held roles at the same companies, or who co-own the same companies

Johan Henrik Faber
Ebumab Sandbox ApS, Ebumab Sandbox ApS, Ebumab Holding ApS, Ebumab Holding ApS, Ebumab Holding ApS, Ebumab Holding ApS, Hemab ApS, Hemab ApS, Cymab ApS, Cymab ApS
Søren Erik Bjørn
Ebumab Holding ApS, Ebumab Holding ApS, Ebumab Sandbox ApS, Cymab ApS, Hemab ApS
Thomas Dal Stenfeldt Batchelor
Ebumab Sandbox ApS, Ebumab Holding ApS, Ebumab Holding ApS, Cymab ApS

Ownership(1)

Wandall Holding ApS
CVR: 37927988
EJERREGISTER
100%
Ownership
Active

Board positions(3)

Ebumab Sandbox ApS
CVR: 43575627
BESTYRELSESMEDLEM
Active
Since 12. okt. 2022
Ebumab Holding ApS
CVR: 39807556
FORMAND
Active
Since 24. aug. 2023
Cymab ApS
CVR: 39859173
FORMAND
Active
Since 17. apr. 2023

Director positions(4)

Ebumab Sandbox ApS
CVR: 43575627
ADM. DIR.
Active
Since 12. okt. 2022
Ebumab Holding ApS
CVR: 39807556
DIREKTØR
Active
Since 24. aug. 2023
Wandall ApS
CVR: 37928097
ADM. DIR.
Active
Since 12. aug. 2016
Wandall Holding ApS
CVR: 37927988
ADM. DIR.
Active
Since 12. aug. 2016

Other roles(1)

Wandall Holding ApS
CVR: 37927988
STIFTERE
Active
Since 12. aug. 2016

Indirect ownership(4)

Companies owned indirectly through ownership chains.

Wandall ApS
CVR: 37928097
100%
Effective ownership
Depth: 1
Ownership path:
Ebumab Holding ApS
CVR: 39807556
15-19,99%
Effective ownership
Depth: 1
Ownership path:
Cymab ApS
CVR: 39859173
15-19,99%
Effective ownership
Depth: 2
Ownership path:
Ebumab Sandbox ApS
CVR: 43575627
15-19,99%
Effective ownership
Depth: 2
Ownership path:

Former board positions(2)

Ebumab Holding ApS
CVR: 39807556
FORMAND
Ended
Since 22. jun. 2020
Until 15. aug. 2023
Hemab ApS
CVR: 40837590
FORMAND
Ended
Since 22. jun. 2020
Until 20. nov. 2020

Former director positions(2)

Ebumab Holding ApS
CVR: 39807556
DIREKTØR
Ended
Since 12. mar. 2019
Until 15. aug. 2023
Cymab ApS
CVR: 39859173
ADM. DIR.
Ended
Since 21. maj 2021
Until 17. apr. 2023

Former roles(1)

Sally Dabelsteen
CVR: 26979943
INTERESSENTER
Dissolved
Ended
Since 1. feb. 2003
Until 30. jun. 2003